脑部放疗,上午比下午敏感许多!
H; v- X; O/ @, N1 R6 w3 u# S. ]2 ~/ c
3 n% G* |7 u) o' M$ I7 R
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
0 z* ?/ |: m; e, l, ZGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, m- k, i2 T+ v& c# A* U- wRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
d: ]4 s% s0 P4 E7 U K$ P. mSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
/ z4 t8 ~4 U# L& u4 s; l& y V( G6 M/ u3 \# |4 U8 a! m
Abstract
6 @# z1 q: A" E' o" D: l+ c) j* mBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.4 R# l* N6 j7 e: D& {) @4 v
7 O/ d7 y( G6 y$ K5 }. {METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.$ ]/ p& P; F: f* [: S6 @, R
4 e' a4 a, N3 h* \9 ^RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).! g% E6 b/ y) ?* A# j
2 f# d$ t4 x+ l3 H2 {: X, `+ g) ^
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
2 D5 X1 R/ E2 }& _8 a) }
. l9 Y5 I9 \0 Y$ _4 i- ^: f |